Literature DB >> 12744847

Risk groups for hepatitis A virus infection.

Elisabetta Franco1, Cristina Giambi, Rita Ialacci, Rosa C Coppola, Alessandro R Zanetti.   

Abstract

We report the conduct and results of a systematic search for evidence of risk of infection with hepatitis A virus (HAV) among blood transfusion recipients, travellers, the military, healthcare workers, sewage workers, foodhandlers, day care assistants, institutionalised subjects, blood transfusion recipients, drug addicts, homosexuals, prisoners and other risk groups such a liver transplantees. We report our recommendations for the use of the HAV vaccine in these groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744847     DOI: 10.1016/s0264-410x(03)00137-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia.

Authors:  Dimitrios Siagris; Alexandra Kouraklis-Symeonidis; Irini Konstantinidou; Myrto Christofidou; Ioannis Starakis; Alexandra Lekkou; Christos Papadimitriou; Alexandros Blikas; Nicholas Zoumbos; Chryssoula Labropoulou-Karatza
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

2.  Vaccination rate and seroepidemiology of hepatitis a in chronic-hepatitis-B-infected individuals in the korean army.

Authors:  Dong Hyuk Shin; Sang Kuk Han; Pil Cho Choi; Seong Woo Lim; Kyung Mook Kim; Dong Hyun Sinn
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

3.  Hepatitis A: Epidemiology and prevention in developing countries.

Authors:  Elisabetta Franco; Cristina Meleleo; Laura Serino; Debora Sorbara; Laura Zaratti
Journal:  World J Hepatol       Date:  2012-03-27

4.  Seroprevalence of anti-HAV among patients with chronic viral liver disease.

Authors:  Hyun Chin Cho; Seung Woon Paik; Yu Jin Kim; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Byung Chul Yoo; Hee Jung Son; Seon Woo Kim
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

5.  The prevalence of hepatitis A in children in British Columbia.

Authors:  Jan J Ochnio; David W Scheifele; Murray Fyfe; Mark Bigham; David Bowering; Paul Martiquet; Margaret Ho; Douglas N Talling
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

6.  Seroprevalence and Molecular Characterisation of Human Hepatitis A virus in Serum Samples of Tunisian Patients with Clinical Symptoms of Viral Hepatitis.

Authors:  Hakima Gharbi-Khelifi; Nabil Ben Salem Abid; Abir Beji; Leila Bhiri; Rafik Harrath; Khira Sdiri; Sylviane Billaudel; Virginie Ferre; Mahjoub Aouni
Journal:  Indian J Virol       Date:  2012-03-25

7.  Seroprevalence of Hepatitis A among Students Enrolled in Tehran University of Medical Sciences during 2011.

Authors:  Anahita Rabiee; Sina Nikayin; Seyed Reza Hashemi; Mostafa Mohaghegh; Marzieh Amini; Roozbeh Rabiee; Shahin Merat
Journal:  Middle East J Dig Dis       Date:  2013-07

8.  Infectious disease risk in asbestos abatement workers.

Authors:  John H Lange; Giuseppe Mastrangelo; Luca Cegolon
Journal:  BMC Public Health       Date:  2012-08-16       Impact factor: 3.295

9.  Changing pattern of hepatitis a virus epidemiology in an area of high endemicity.

Authors:  Marcello Campagna; Andrea Siddu; Angelo Meloni; Claudia Basciu; Luigi Ferrai; Alessandro Pettinau; Cristiana Cardia; Giuseppina Masia; Rosa Cristina Coppola
Journal:  Hepat Mon       Date:  2012-06-30       Impact factor: 0.660

10.  Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control study.

Authors:  Joo Youn Seo; Bo Youl Choi; Moran Ki; Hye Lim Jang; Hee Suk Park; Hyun Jin Son; Si Hyun Bae; Jin Han Kang; Dae Won Jun; Jin-Woo Lee; Young Jin Hong; Young Seok Kim; Chang-Hwi Kim; U Im Chang; Jong-Hyun Kim; Hyeon Woong Yang; Hong Soo Kim; Kyeong Bae Park; Jae Seok Hwang; Jeong Heo; In Hee Kim; Jung Soo Kim; Gab Jin Cheon
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.